Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scientist Home Future HealthSHFH +11.11%8 Return-on-Tangible-Equity is 0.00% as of Jun. 2026. GuruFocus rates SHFH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 581 Healthcare Providers & Services companies, Scientist Home Future Health ranks worse than 98.45% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Scientist Home Future Health's annualized net income for the quarter that ended in Jun. 2026 was $-0.39 Mil. Scientist Home Future Health's average shareholder tangible equity for the quarter that ended in Jun. 2026 was $-0.04 Mil. Therefore, Scientist Home Future Health's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was N/A%.
The historical rank and industry rank for Scientist Home Future Health's Return-on-Tangible-Equity or its related term are showing as below:
SHFH'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -561.62 Med: -433.64 Max: -433.64
Current: -561.62
During the past 2 years, Scientist Home Future Health's highest Return-on-Tangible-Equity was -433.64%. The lowest was -561.62%. And the median was -433.64%.
SHFH's Return-on-Tangible-Equity is ranked worse than 98.45% of 581
companies
in the Healthcare Providers & Services industry
Industry Median: 10.72
vs SHFH: -561.62
Scientist Home Future Health (OTCPK:SHFH) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Scientist Home Future Health Return-on-Tangible-Equity Related Terms
Scientist Home Future Health Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientist Home Future Health Return-on-Tangible-Equity Chart
SHFH vs BHIC, PETS, SCNX: Return-on-Tangible-Equity Comparison
For the Pharmaceutical Retailers subindustry, Scientist Home Future Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientist Home Future Health Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scientist Home Future Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Scientist Home Future Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Scientist Home Future Health (SHFH) has a Return-on-Tangible-Equity of 0.00% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Scientist Home Future Health and its competitors. According to the industry distribution chart, Scientist Home Future Health ranks #572 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 98.5%.
Is Scientist Home Future Health's Return-on-Tangible-Equity too high?
Scientist Home Future Health's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Scientist Home Future Health ranks #572 out of 581 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Scientist Home Future Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scientist Home Future Health's Return-on-Tangible-Equity compare to BHIC and PETS?
According to the Healthcare Providers & Services industry distribution chart, Scientist Home Future Health ranks #572 out of 581 companies for Return-on-Tangible-Equity. This places Scientist Home Future Health in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.72, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Scientist Home Future Health and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientist Home Future Health's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientist Home Future Health stock overvalued right now?
Scientist Home Future Health (SHFH) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Scientist Home Future Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Scientist Home Future Health (SHFH), the current Return-on-Tangible-Equity is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scientist Home Future Health Ltd, through its subsidiaries, engages in the retail trading of health supplements and topical creams and provision of physical check-up services in Hong Kong. It focuses on developing sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that the products not only address current symptoms but also support future, long-term health and recovery. The company has two reportable segments based on business unit, retail trading and service business. The majority of revenue is derived from the Retail Trading segment, which derives revenue from customers by providing health supplements and topical creams. It has two reportable segments based on geographical location: Hong Kong and Non-Hong Kong; key revenue derives from Hong Kong.
8GF Score
Get the complete analysis for SHFH
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHFH has been successfully added to your 
